Published in Paediatr Child Health on July 01, 2002
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet (1997) 3.10
Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child (1992) 1.85
Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr (1998) 1.77
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr (1993) 1.64
Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child (1994) 1.55
Idiopathic thrombocytopenic purpura in children: diagnosis and management. Pediatrics (1975) 1.15
Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics (1981) 1.08
Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol (1984) 1.05
The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr (1987) 1.04
Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med (1998) 1.03
Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child (1988) 0.99
Idiopathic thrombocytopenic purpura and intracranial hemorrhage. Pediatrics (1981) 0.93
Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids. Am J Pediatr Hematol Oncol (1984) 0.90
Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl (1998) 0.90
Autoimmune thrombocytopenic purpura. Hematol Oncol Clin North Am (1990) 0.83
Childhood acute idiopathic thrombocytopenic purpura: how many tests and how much treatment required? J Pediatr (1985) 0.79
Are randomized clinical trials the only truth? Not always. J Thromb Haemost (2006) 3.34
Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet (1995) 3.31
Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia (2007) 2.17
Screening for celiac disease in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr (2001) 1.70
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet (2002) 1.56
Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol (1995) 1.45
A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis. Surg Endosc (2006) 1.42
Familial hyperinsulinism: successful conservative management. J Pediatr (1991) 1.18
National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics (1993) 1.17
Use of lidocaine-prilocaine cream for vaccination pain in infants. J Pediatr (1994) 1.17
Controlled study of respiratory viruses and wheezing. Arch Dis Child (2002) 1.15
Accuracy of clinical assessment of heart murmurs by office based (general practice) paediatricians. Arch Dis Child (1999) 1.15
Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost (2009) 1.07
Helicobacter pylori and childhood recurrent abdominal pain: community based case-control study. BMJ (1999) 1.02
Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs). Med Decis Making (2003) 0.99
Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A. Haemophilia (2008) 0.98
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Haemophilia (2008) 0.97
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. Haemophilia (2008) 0.96
Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes--Kids Life Assessment Tool (CHO-KLAT). Haemophilia (2004) 0.95
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia (2008) 0.94
Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. J Med Genet (2011) 0.93
Clinical trial design in haemophilia. Haemophilia (2012) 0.92
Velocardiofacial syndrome presenting as hypocalcemia in early adolescence. Arch Pediatr Adolesc Med (1997) 0.90
Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials. Haemophilia (2011) 0.90
Congenital hypopituitarism and conjugated hyperbilirubinemia in two infants. Am J Dis Child (1978) 0.88
A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J Thromb Haemost (2004) 0.88
Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada. J Thromb Haemost (2012) 0.87
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia (2013) 0.86
Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group. Clin Infect Dis (1995) 0.86
National survey of neonatal transfusion practices: II. Blood component therapy. Pediatrics (1993) 0.85
Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res (1994) 0.85
Cross-cultural validation of the CHO-KLAT and HAEMO-QoL-A in Canadian French. Haemophilia (2011) 0.85
The changing face of hepatitis in boys with haemophilia associated with increased prevalence of obesity. Haemophilia (2011) 0.84
Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia (2008) 0.83
Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplant (2000) 0.83
Hepatitis A and B immunization for individuals with inherited bleeding disorders. Haemophilia (2009) 0.83
When should prophylaxis therapy in inhibitor patients be considered? Haemophilia (2011) 0.83
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med (2005) 0.83
Effect of intracranial bleeds on the neurocognitive, academic, behavioural and adaptive functioning of boys with haemophilia. Haemophilia (2011) 0.82
Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders. Haemophilia (2006) 0.82
Outcome measures in haemophilia: more than just factor levels. Haemophilia (2004) 0.82
Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding. Haemophilia (2007) 0.81
Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol (2000) 0.81
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions. Transfus Med (2000) 0.81
Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol (1998) 0.81
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group. Haemophilia (2007) 0.80
Importance of literacy for self-reported health-related quality of life: a study of boys with haemophilia in Brazil. Haemophilia (2013) 0.80
Permeabilization and fixation conditions for intracellular flow cytometric detection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations. Cytometry (1998) 0.80
A survey of factor prophylaxis in the Canadian haemophilia A population. Haemophilia (2004) 0.80
A survey of Canadian neonatal blood transfusion practices. Transfus Sci (1997) 0.80
Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody. Blood (1993) 0.80
Carrier detection of haemophilia A using DNA markers in families with an isolated affected male. Clin Genet (1987) 0.80
Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study. J Thromb Haemost (2013) 0.80
Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants. Pediatr Res (1996) 0.80
Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII. Br J Haematol (1996) 0.79
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol (1990) 0.79
Random donor platelet crossmatching: comparison of four platelet antibody detection methods. Am J Hematol (1988) 0.79
Cost of severe haemophilia in Toronto. Haemophilia (2005) 0.79
Idiopathic thrombocytopenia and neutropenia in childhood. Am J Pediatr Hematol Oncol (1994) 0.79
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr (1995) 0.79
Application of current knowledge to the management of bleeding events during immune tolerance induction. Haemophilia (2006) 0.78
Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura. Br J Haematol (1999) 0.78
A complete deletion of the factor IX gene and new TaqI variant in a hemophilia B kindred. Hum Genet (1988) 0.78
Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies. J Pediatr (1991) 0.78
Unresolved issues in prophylaxis. Haemophilia (2002) 0.78
A Canadian survey of self-infusion practices in persons with haemophilia A. Haemophilia (2012) 0.78
Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. Am J Hematol (2002) 0.78
Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Haemophilia (2011) 0.78
A systematic review of MR imaging as a tool for evaluating haemophilic arthropathy in children. Haemophilia (2013) 0.77
Consequences of delayed therapy for sports-related bleeds in patients with mild-to-moderate haemophilia and type 3 von Willebrand's disease not on prophylaxis. Haemophilia (2013) 0.77
Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT. Haemophilia (2006) 0.77
Response to hepatitis B immunization in children with hemophilia: relationship to infection with human immunodeficiency virus type 1. J Pediatr (1990) 0.77
Pain perception and effectiveness of the eutectic mixture of local anesthetics in children undergoing venipuncture. Pediatr Res (1992) 0.77
Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice. Br J Haematol (1999) 0.77
The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report. Haemophilia (2009) 0.77
Analysis of platelets by flow cytometry. Transfus Sci (1995) 0.77
Cost-effectiveness analysis of different imaging strategies for diagnosis of haemophilic arthropathy. Haemophilia (2009) 0.77
A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients. Transfusion (1989) 0.77
Ultrasound and magnetic resonance imaging of healthy paediatric ankles and knees: a baseline for comparison with haemophilic joints. Haemophilia (2015) 0.77
Management of bleeding disorders in adults. Haemophilia (2012) 0.76
Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes. Transfusion (1999) 0.76
High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr (1988) 0.76
Different clinical phenotype in triplets with haemophilia A. Haemophilia (2007) 0.76
Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489). Tissue Antigens (1997) 0.76
Acquired von Willebrand syndrome in paediatric patients with congenital heart disease: challenges in the diagnosis and management of this rare condition. Haemophilia (2014) 0.75
Evaluation of Fever in a child aged three months to 24 months. Can Fam Physician (1990) 0.75
Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach. Haemophilia (2006) 0.75
Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010. Haemophilia (2014) 0.75
Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11. Clin Infect Dis (1998) 0.75
The Gap Study (GapS) interview--developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic disease. Clin Exp Rheumatol (2007) 0.75
Platelet activation induced by porcine factor VIII (Hyate:C). Am J Hematol (1998) 0.75
Acute haemarthrosis of the hip joint: rapid convalescence following ultrasound-guided needle aspiration. Haemophilia (2008) 0.75
Evaluation of a simple immunodiffusion technique for quantitation of platelet-associated immunoglobulin G in childhood immune thrombocytopenias. Am J Pediatr Hematol Oncol (1985) 0.75